CSL Limited

CSL is a leading global biotechnology company with a portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL — including our two businesses, CSL Behring and Seqirus - provides life-saving products to more than 60 countries and employs nearly 20,000 people.
CSL has a significant R&D presence in Australia, led from the company’s main Parkville campus which is home to CSL’s corporate head office and significant R&D and manufacturing facilities. In addition, the company’s global hub for Early Research and Translational Medicine is based at the University of Melbourne's Bio21 Institute in the Parkville biomedical precinct.